surmount 4 tirzepatide Adults with obesity using maintain 'remarkable' weight loss at 88 weeks Nutritional status with tirzepatide in
Description
doi: 10.1002/hep.29367 184 BramanteCTignanelliCJDuttaNJonesETamarizLClarkJMet al
4 The obesity trial showed weight loss up to about 24% at 48 weeks, and the diabetes trial showed HbA1c reductions up to about 2 percentage points
This is a good problem to have, but it requires coordination
It is important for patients considering Tirzepatide to undergo a thorough medical evaluation, including blood work, to assess their overall health and eligibility for the treatment
So about 5 pounds of 200 pound person difference See more comments To view or add a comment, sign in More Relevant Posts Less than 24 hours ago, I asked about experiences with unapproved GLP-1 products
Understanding Compounded Semaglutide Side Effects. Medivera RX , Accessed September 2024
